4//SEC Filing
Nazak Michael Adrian 4
Accession 0001104659-21-026339
CIK 0001614067other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 8:08 PM ET
Size
5.2 KB
Accession
0001104659-21-026339
Insider Transaction Report
Form 4
Nazak Michael Adrian
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Options
2021-02-18+20,000→ 80,000 totalExercise: $7.84Exp: 2031-02-18→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The stock options vest in equal installments over 48 months, beginning on February 1, 2021.
Documents
Issuer
Aridis Pharmaceuticals, Inc.
CIK 0001614067
Entity typeother
Related Parties
1- filerCIK 0001799731
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 8:08 PM ET
- Size
- 5.2 KB